Gates Foundation Gives Glaser Foundation $9.7 Million for Research on Pediatric HIV Vaccines; Research to Focus on Breast-Feeding Infants
May 18, 2007
The Bill & Melinda Gates Foundation has awarded the Elizabeth Glaser Pediatric AIDS Foundation a five-year, $9.7 million grant to research and develop experimental HIV vaccines aimed at children, Glaser Foundation President and CEO Pamela Barnes announced Friday on HIV Vaccine Awareness Day, the AP/Houston Chronicle reports. The research will focus on preventing mother-to-child transmission of the virus through breastmilk, according to the Glaser Foundation. The grant will fund eight research studies and up to three pediatric clinical trials of HIV vaccines previously tested among adults. Barnes said nearly 14% of all new HIV cases worldwide occur among infants who contract the virus from their mothers, most of whom rapidly develop AIDS because they lack treatment access (Gordon Blankinship, AP/Houston Chronicle, 5/18). The preclinical research studies will examine issues related to HIV transmission through breastmilk and pediatric immunity.
Back to other news for May 2007
HIV Screening in Hospital EDs Might Be More Cost Effective Than Other Screening Methods, Study Finds
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.